Skip to main content
JA Clinical Reports logoLink to JA Clinical Reports
letter
. 2024 Feb 3;10:9. doi: 10.1186/s40981-023-00681-1

In-reply to the comment by Poling et al

Kyosuke Takahashi 1,2,, Kotaro Sakurai 3, Izumi Hamaya 4
PMCID: PMC10838255  PMID: 38308702

To the editor

We thank Poling et al. for their interest in our report [1]. They raised the importance of a new disease concept and optimal management according to the diagnosis.

As they pointed out, the diagnosis of Freeman-Sheldon syndrome (FSS) (What they call Freeman-Burian syndrome [FBS]) is difficult due to similar physical characteristics between FSS/FBS and Sheldon-Hall syndrome. We think our case was not typical of FSS/FBS. Although she had multiple arthrogryposes and prominent nasolabial folds, microstomia was not severe, midface hypoplasia was mild, and tracheal intubation was easy during anesthesia. However, this does not exclude the diagnosis of FSS/FBS.

The association between distal arthrogryposis and malignant hyperthermia remains uncertain. An observational study that investigated 73 individuals referred with the diagnosis of FSS revealed that 3 out of 10 patients developed malignant hyperthermia when they had surgery [2]. On the other hand, a study reported no association between malignant hyperthermia and distal arthrogryposis [3]. Considering the mixed findings of past studies, it is still safe to avoid inhalation anesthetics because we have many alternative options without them. Hence, our strategy using propofol, opioids, and dexmedetomidine was a reasonable choice for the patient who underwent cardiac surgery. Further studies with large sample sizes are needed to determine the association between malignant hyperthermia and this syndrome. Until this question is resolved, providing malignant-hyperthermia-safe anesthesia for patients with FSS/FBS is warranted.

Acknowledgements

Not applicable.

Abbreviations

FBS

Freeman Burian Syndrome

FSS

Freeman Sheldon Syndrome

Authors’ contributions

KT wrote the manuscript. KS and IH critically reviewed and supervised the manuscript. All authors checked and approved the final version of the manuscript.

Funding

Not applicable.

Availability of data and materials

Not applicable.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Takahashi K, Sakurai K, Hamaya I. Anesthetic management of a pediatric patient with Freeman-Sheldon syndrome undergoing atrial septal defect closure: a case report. JA Clin Reports Springer, Berlin Heidelberg. 2023;9:9–12. doi: 10.1186/s40981-023-00633-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Stevenson DA, Carey JC, Palumbos J, Rutherford A, Dolcourt J, Bamshad MJ. Clinical characteristics and natural history of Freeman-Sheldon syndrome. Pediatrics. 2006;117:754–762. doi: 10.1542/peds.2005-1219. [DOI] [PubMed] [Google Scholar]
  • 3.Gleich SJ, Tien M, Schroeder DR, Hanson AC, Flick R, Nemergut ME. Anesthetic Outcomes of Children with Arthrogryposis Syndromes: No Evidence of Hyperthermia. Anesth Analg. 2017;124:908–914. doi: 10.1213/ANE.0000000000001822. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from JA Clinical Reports are provided here courtesy of Springer

RESOURCES